I wrote a few months ago about a case at the boards of appeal, T 697/22, where a possible referral to the Enlarged Board (EB) on the question of whether description amendments are required. At the time, the board were considering four questions to be raised to the EB to resolve the issue, and asked the parties to the appeal proceedings for comments. The parties then provided comments and the board has now issued their decision. Three of the questions initially proposed are now to be referred, which are:
1. If the claims of a European patent are amended during opposition proceedings or opposition-appeal proceedings, and the amendment introduces an inconsistency between the amended claims and the description of the patent, is it necessary, to comply with the requirements of the EPC, to adapt the description to the amended claims so as to remove the inconsistency?
2. If the first question is answered in the affirmative, which requirement(s) of the EPC necessitate(s) such an adaptation?
3. Would the answer to questions 1 and 2 be different if the claims of a European patent application are amended during examination proceedings or examination-appeal proceedings, and the amendment introduces an inconsistency between the amended claims and the description of the patent application?
The case in question related to a patent that was opposed and then maintained in amended form. Both parties appealed and the Board ended up deciding that the claims on file according to an auxiliary request were allowable. Due to amendments made to the claims, however, there then existed an inconsistency between claim 1 and parts of the description that described certain claimed features as optional. Based on what was then on file, the Board had to decide whether this inconsistency was in contravention of the requirement of Article 84 EPC that the claims must be supported by the description. The decision that needed to be made was whether this inconsistency made the request allowable or not allowable, giving rise to the first question.
The Board reviewed the existing case law and found some decisions that were in favour of aligning the description with the claims and others that were not. This resulted in two lines of case law that were clearly diverging.
According to the first line of case law, adaptation of the description was required when amendments to claims introduced inconsistencies. The leading case on this was identified as T 1024/18, which stated: "According to long established case law of the Boards of Appeal, [Article 84] has been interpreted as requiring the entirety of the description to be consistent with any claims found to meet the requirements of the EPC." This reasoning was followed by T 447/22, T 2685/19, T 1516/20, T 121/20, T 2293/18, T 1968/18, T 2766/17, T 2378/13 and T 3097/19. Other decisions that also came to the same conclusions included T 169/20, T 673/22 and T 1784/21. In all these decisions, the Board found that the common underlying principle was that there is a legal basis requiring the description to be consistent with the amended claims. Although the principle legal basis provided in most cases was Article 84 EPC, this was not consistently applied. Some decisions cited Rule 42 EPC, either alone or in combination with Article 84, while others referred to a more general legal requirement or cited other provisions including Rules 48 and 71(1) in support.
According to the second line of case law, which had developed more recently, there was no legal basis for refusing a patent application if there was an inconsistency between any amended claims and the description. This line of case law was started by T 1989/18, which was followed by T 1444/20 and most recently and prominently T 56/21 (see my post here). Other decisions such as T 2194/19 also reached a similar conclusion. According to this line of case law, any inconsistencies between the claims and the description were the applicant's responsibility alone. T 1989/18 for example found that, if the claims were clear in themselves, their clarity was not affected by the description containing unclaimed subject matter, while the board in T 2194/19 rejected both Article 84 and Rule 42 EPC as a basis for adaptation of the description. The board in T 56/21 went further in finding that neither Article 84 EPC nor Rules 42, 43 or 48 provided a legal basis for requiring the description to be amended.
The Board also referred to a recent UPC decision from Sweden (AGFA NV v Gucci Sweden AB), which found that, although the description should always be referred to when interpreting the claims (which of course is now also a requirement at the EPO following G 1/24), an apparent inconsistency between the claims and the description was not an impediment to upholding a patent with a broader description than a more limited claim. A patent proprietor could not, however, rely on such an inconsistency to interpret a limited claim.
In summary, the Board decided that question 1 was needed because this determined whether the patent in question was allowable or not and was necessary to resolve the disagreement in the divergent case law. Question 2 was needed to determine, if there was such a requirement, what the legal basis was. Finally, question 3 was needed because the same issue arose during examination proceedings, which the more recent case law had come from. The Board also made reference to G 1/24, following which the question of whether an application could be granted or a patent upheld if there was an inconsistency had become of even greater significance.
We will now therefore finally, after a couple of previous false starts, get the chance to find out if the EPO's current practice in requiring applicants to amend the description is correct, which many find to be an unnecessary burden, or if the whole thing should be scrapped. I know which way I would decide. We will, however, need to wait a little while to find out.
UPDATE 5/8/25: The EPO has issued a notice mentioning the G 1/25 referral and which states that "the President of the EPO has decided that proceedings before the examining and opposition divisions should continue". This will mean that the current Guidelines for Examination will continue to apply while the referral is pending and that cases where amendments to the description have been required will not be stayed pending outcome of the referral. Given that this will apply to practically all applications currently pending at the EPO, this is not very surprising. The EPO would clearly prefer it if proceedings did not grind to an almost complete halt while the Enlarged Board consider which way to go.